WD repeat 79 protein targeted therapy

Details for Australian Patent Application No. 2010278729 (hide)

Owner New York Blood Center, Inc.

Inventors Chen, Ying; Huang, Cheng-han; Ye, Mao

Agent Pizzeys

Pub. Number AU-A-2010278729

PCT Pub. Number WO2011/014816

Priority 61/230,453 31.07.09 US

Filing date 30 July 2010

Wipo publication date 3 February 2011

International Classifications

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

Event Publications

9 February 2012 PCT application entered the National Phase

  PCT publication WO2011/014816 Priority application(s): WO2011/014816

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010278730-Pyrrolo [1, 2-b] pyridazine derivatives as janus kinase inhibitors

2010278721-Modified factor IX polypeptides and uses thereof